Rain Oncology
CA - NewarkBiotechnology
Focus: Rain Oncology is an early-stage oncology-focused biotech company specializing in small molecule therapeutics, publicly traded but with limited commercial infrastructure. The company operates from Newark, CA with a portfolio spanning solid tumors, breast cancer, and lung cancer indications.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
38+38 this month
Hot — 40 jobs added in 30d
Net +38 (40 new, 2 removed). Aggressive expansion phase.
Should You Work at Rain Oncology?
AI assessmentRain Oncology presents a high-risk, high-reward opportunity suited only to early-stage biotech professionals comfortable with clinical-stage uncertainty and valuation volatility.
Why Work Here
- Phase 3 program (RAIN-32 in dedifferentiated liposarcoma) offers near-term value creation potential in a rare cancer indication
- Public company status provides equity liquidity and institutional credibility absent in pre-revenue startups
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Placebo
Cardiac RepolarizationClinical Trials (1)
NCT05758818A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects
Phase 1Help build intelligence for Rain Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.